Vidscrip allows doctors to record answers to commonly asked patient questions and share them directly to patients or on their clinic’s website. Recording these videos for patients, to watch at their own pace, reduces the number of times a doctor needs to answer questions as well as maximizes information retention by the patient.
Doctors are busy people with a lot of things to juggle from clinic hours and hospital calls to patient charts and staying updated on latest research and studies. To ensure high quality videos without expecting doctors to learn a dedicated or complex video recording tool, we designed an easy to use browser based tool that rolled all their recording, editing, and sharing needs into one application.
Right after surgery, getting a diagnosis or when needing to make a care decision, patients are often left feeling vulnerable. Doctors do their best to equip patients with the right information so they are often given packets of information or numerous sets of instructions. All of the information, while helpful, can all be overwhelming. Vidsrips allow patients to digest the information at their own pace, in their own time, while still directly from their own doctor.
After building the recording and sharing side of the application, it was important to enable many different delivery methods to best facilitate doctor - patient communication. Vidscrips are shareable both as personal SMS messages or can be embedded as widgets into any website.
The early work on this application was setting up Vidscrip for success, but as the landscape of telemedicine changed with the COVID-19 outbreak, so did our engagement with Viscrip. With an increased dependency on virtual care, we needed to ramp up on Vidscrip servers, implement load tests, identify bottlenecks, reduce api calls and the overall maximize the performance of their application.
As our country becomes more dependent on telemedicine, we are excited to be continuing our engagement with Vidscrip and enabling them to be a leader in the future of telemedicine.